Prof. Dr. med. Carola Berking

Lehrstuhl für Haut- und Geschlechtskrankheiten

Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data (2025) Sponfeldner M, Dürr P, Lensker P, Geßner K, Cuba L, Fietkau R, Neurath M, et al. Journal article Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma. (2025) Tomsitz D, Livingstone E, Loquai C, Kaatz M, Leiter U, Schilling B, Terheyden P, et al. Journal article Real-World Use of Topical Ruxolitinib in Vitiligo: Retrospective Cross-Sectional Mixed Methods Infodemiology Study of the r/Vitiligo Subreddit (2025) Kirchberger MC, Berking C, Eisenried A Journal article Real-world evidence of tirbanibulin in the treatment of actinic keratosis in Germany – prospective, multicenter, non-interventional KLIR study (2025) Heppt M, Hadshiew I, Kempf A, Melzer A, Berking C Journal article Extracorporeal photopheresis reduces the T cell stimulatory capacity of human primary blood conventional dendritic cells type 1 (2025) Heger L, Berking C, Hackstein H Journal article Hazard rates and implications for follow-up schedules of melanoma patients with 0.8–1.0 mm tumor thickness: An analysis of the German Central Malignant Melanoma Registry in 12,132 patients (2025) Aebischer V, Nanz L, Amaral T, Berking C, Eigentler T, Flatz L, Forschner A, et al. Journal article Multiple squamous cell carcinomas arising in linear porokeratosis Multiple Plattenepithelkarzinome auf einer linearen Porokeratose (2025) Busch D, Berking C, Schliep S, Erfurt-Berge C Journal article Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics (2025) Cuba L, Dörje F, Kramer R, Dürr P, Erdmann M, Fromm M, Berking C, Geßner K Journal article Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp. (2025) Reinhold U, Philipp-Dormston WG, Dirschka T, Ostendorf R, Aschoff R, Berking C, Jäger A, et al. Journal article Long-term follow-up of real-world adjuvant anti-PD1 checkpoint inhibition and targeted therapy in stage III melanoma patients (2025) Lodde GC, Hassel JC, von Wasielewski I, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article